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Since conventional culture-based antimicrobial susceptibility testing (AST) methods are too 
time-consuming (> 24-72 h), rapid AST is urgently needed for preventing the increasing 
emergence and spread of antimicrobial resistant infections. Although several phenotypic 
antibiotic resistance sensing modalities are able to reduce the AST time to a few hours or 
less, concerning the biological heterogeneity, their accuracy or limit of detection are limited 
by low throughput. Here, we present a rapid AST method based on whole slide imaging 
(WSI)-enabled high-throughput monitoring microbial growth at single-cell level. The time 
for determining the minimum inhibitory concentration (MIC) can be sufficiently short to 
ensure that the growth of each individual cell present in a large population is inhibited. As a 
demonstration, our technique was able to monitor the growth of several thousand microbes 
at single-cell level. Reliable MIC for bacteria and fungi was obtained in 1 h and 3 h, 
respectively. In addition, the application of our method prevails over other imaging-based 
AST approaches in allowing accurate determination of antibiotic susceptibility for 
phenotypically heterogeneous samples, in which the number of antimicrobial resistant cells 
was negligible compared to that of the susceptible cells. Hence, our method shows great  
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1.1 The crisis of antimicrobial resistance 
1.1.1 The emergence of antimicrobial resistance 
Since the discovery of penicillin by Sir Alexander Fleming in 1928, antibiotics have 
saved millions of lives from bacterial infections and extended life spans of human [1]. 
Despite the remarkable benefits of antibiotics, antimicrobial resistance (AMR) has been 
noticed as a threat to public health since the emergence of methicillin-resistant 
Staphylococcus aureus (MRSA) in 1960s [2]. Unfortunately, shortly thereafter, AMR has 
been eventually developed to almost all antibiotics (Figure 1) [3]. Particularly, it had been 
believed that the resistance against vancomycin was unlikely to occur, but vancomycin 
resistance was reported only 7 years since the introduction of it to clinical practice in 1972 
[2]. Although the pharmaceutical industry has been developing new antibiotics to solve the 
AMR issue, the pipeline of antimicrobial agents is becoming dry up, which has facilitated 
the outbreak of multidrug-resistant microbes, which is also referred to as “superbugs” [4].  
According to a report published by Centers for Disease Control and Prevention (CDC) 
in 2013, the top 18 AMR threats, including bacteria and fungi, were outlined [5]. They are 
categorized as “urgent”, “serious”, or “concerning” based on the threat level (Table 1). This 
report sounded an alarm to the danger of AMR infections. In the U.S., over 2 million people 




Figure 1. A timeline of AMR development [3]. 
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1.1.2 The causes of the antimicrobial resistance crisis 
1.1.2.1 Overuse of antimicrobial agents 
Apparently, the overuse of antimicrobial agents is considered as a major driving force 
for the evolution of AMR. Based on Darwinian theory of evolution, antibiotic stress selects 
the antibiotic-resistant bacteria to survive by eliminating the antibiotic-sensitive bacteria [6]. 
Although warnings are posted to reduce the overuse, antibiotics are overprescribed 
worldwide [7]. Especially in many developing countries, the lacking of regulations allows 
Table 1. CDC assessment of AMR threats [5]. 

























Group A Streptococcus 
Clindamycin-resistant 













that the antibiotics are available over the counter without a prescription [8]. In addition to 
prescription to human patients, antibiotics are extensively used in agriculture. According to 
an estimate, 80% of the antibiotics sold in the U.S. are used in livestock as growth 
supplements to improve the overall health of the farm animals [9]. As the consequence of 
overusing antibiotics in livestock, resistant bacteria have been found to infect humans 
through the food supply [10]. Moreover, as reported in a recent study, triclosan, a non-
antibiotic antimicrobial agent commonly seen in toothpaste and hand washing, induces 
multi-drug resistance through genetic mutation, suggesting that antibacterial products for 
hygienic purpose may also cause AMR [11].  
1.1.2.2 Inappropriate prescribing 
Inappropriate prescribing of antimicrobial agents is also considered to be responsible 
for the rising AMR. Studies have revealed that antibiotic therapy decisions, including the 
choice of antimicrobial agents or the duration of the treatments, are incorrect in 30-50% 
cases [5, 6, 12]. Particularly in intensive care units (ICU), 30-60% of the antibiotic 
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prescriptions have been identified to be unnecessary, inappropriate, or suboptimal [13]. For 
instance, using broad-spectrum antibiotics, such as quinolones or imipenem, contributes 
more to the rising resistance than using narrow spectrum-antibiotics, such as amoxicillin, 
cephalexin, or trimethoprim-sulfamethoxazole [14]. As broad-spectrum antibiotics non-
selectively kill bacteria, they cause serious disturbance of gut flora. This disturbance 
facilitates the thriving emergence of resistance and the transfer of resistance to other species 
of bacteria [15].   
1.1.2.3 Fewer new antimicrobial agents 
Although there is an increasing need of new drugs to combat the rising AMR, the 
pipeline of new antimicrobial agents is continuously shrinking. Unfortunately, as depicted 
in Figure 2, no new antibiotic launched into the market in 2013-2016, which has aggravated 
the threat of AMR. As one reason behind it, the pharmaceutical industry no longer considers 
the development of new antimicrobial drugs as an economically wise investment. In addition 
to the low cost, physicians typically prescribe the new antibiotics as “last-line” drugs, which 
leads to the reduced use and diminished return to the investment [1, 16]. As another reason, 
when the new drugs are eventually introduced into the clinical practices, the microbes adapt 
to them very fast and the emergence of new resistance is inevitable [16]. Therefore, due to 




Figure 2. The number of antibiotic-resistant bacteria is increasing while the number 
of new antibiotics is continuously decreasing [17]. 
1.1.3 The clinical and economic burden of antimicrobial resistance 
As the second leading killer in the world, infectious disease causes 17 million deaths 
each year. In the U.S., approximately 2 million people are infected with antibiotic-resistant 
bacteria (“superbugs”) and 23,000 of them die [5]. If there is no global action to curb the 
AMR, the number of deaths would increase to 10 million per year and cost the global 
economy up to $100 trillion by 2050 [18]. Moreover, 28 million people would be pushed 
into poverty. As a major example of AMR threat, MRSA causes 19,000 deaths and 360,000 
hospitalization each year in the U.S, along with $3-4 billion costs in healthcare [19].  
1.2 Tackling the crisis of antimicrobial resistance 
1.2.1 Government initiatives 
To combat the crisis of AMR, the U.S. government has offered incentives to encourage 
large pharmaceutical industry to return to antibiotic discovery. Biomedical Advanced R&D 
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Authority of the U.S. government has supported companies, such as GSK ($200 million) 
and Cempra ($75 million), to develop new antibiotics [20]. In 2012, the European Innovative 
Medicines Initiatives started the “New Drugs 4 Bad Bugs” (ND4BB) project. This project 
contributed $134 million to the development of new antibiotics [21]. In March 2015, the U.S. 
White House issued a national action plan to combat AMR. The plan aimed to reduce half 
of the infections caused by some of the most lethal microbes within 5 years [22]. The White 
House also hopes to fund the discovery of new antimicrobial agents to kill “superbugs” and 
the innovation of novel diagnostic tools to rapidly detect them.  
1.2.2 Preventing transmission of microbial infections 
It is known that cross-transmission of resistant microbes, especially those with high 
potential to spread (e.g. Clostridium difficile or carbapenem-resistant Enterobacteriaceae), 
places patients at high-risk [12]. Therefore, it is critical for the healthcare providers to 
comply with the CDC infection-control guidelines. For example, hand hygiene before and 
after patient contact is essential to reduce the chance of transmission. In addition, 
disinfection of healthcare working environment and medical equipment is also required. As 
another preventative strategy required by CDC, contact tracking is conducted to trace 
individuals who are infected and their contacts who may have been transmitted [10]. Notably, 
contact tracking has successfully limited the spread of AMR. 
1.2.3 Developing new antimicrobial agents and therapeutic strategies 
There is an urgent global need for new antimicrobial agents to combat the crisis. 
Although only five new antibiotics were approved for clinical use during the decade between 




Figure 3. Number of novel FDA-approved antimicrobial drugs each year [23]. 
Typically, a fixed regimen (e.g. dose, dosage frequency, and length of treatment) is 
associated with antimicrobial therapy. Such treatment generally last 5-7 days or longer [8]. 
However, recent studies of clinical trials have discovered that shorter courses of therapy are 
just as effective as longer ones, indicating that prolonged treatment may be unnecessary [4, 
13]. To prevent the enrichment of antibiotic-resistant bacteria, a limited antibiotic dose and 
a shorter course of treatment is preferred.  
As alternative solutions to treat antibiotic-resistant bacteria, more understanding of 
resistance mechanisms has facilitated the generation of new chemicals that can extend the 
life of existing antibiotics [24]. For example, a variety of inhibitors of major enzymes that 
are responsible for the inactivation of antibiotics, such as beta-lactamase and 
aminoglycoside-resistance enzymes, have been developed to overcome the barriers of 
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resistance [25-29]. Furthermore, suppressing antibiotic efflux with inhibitors of efflux pump 
proteins provides another strategy to improve the antimicrobial activities [30-33].  
1.2.4 Reducing inappropriate use of antibiotics 
Empirical use of antibiotics could be reduced by more rapid and accurate diagnosis [34, 
35]. Typically, healthcare providers perform antimicrobial susceptibility testing (AST) to 
guide the antibiotic prescription. In clinical practice, AST is employed to assess the 
effectiveness of an antimicrobial agent against certain microbe. The results of AST are 
reported in the form of minimum inhibitory concentration (MIC), which is the lowest 
concentration of an antimicrobial agent that inhibits visible growth of a microbe [36]. Since 
the most routinely used culture-based AST methods generally take 24-72 hours, initial 
treatment is often empirical, which results in poor outcomes, increased mortality, and 
prolonged hospitalization [37, 38]. Particularly, for patients with septic shock or bacterial 
meningitis, empirical antibiotic therapy should be initiated immediately based on the 
urgency. In an initial empirical therapy, broad-spectrum antibiotics are commonly used. 
Later, the spectrum of antibiotics is narrowed according to the AST results. Therefore, rapid 
and accurate AST approaches is urgently needed to reduce the empirical use of broad-
spectrum antibiotics and consequent increasing emergence and spread of antibiotic 
resistance. 
1.3 An overview of antimicrobial susceptibility testing (AST) methods 
1.3.1 Conventional culture-based AST methods 
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1.3.1.1 Broth dilution methods 
Broth dilution methods, which are used to measure the MICs of antimicrobial agents, 
are one of the gold standard methods for AST. In broth dilution tests, a known number of 
microorganisms are inoculated into tubes containing dilutions of antimicrobial agent. As 
described in Figure 4, the lowest concentration of an antimicrobial agent, at which no visible 
growth appears within certain period of time, is defined as the MIC [39]. The classic broth 
dilution requires the broth volume in the testing tube is at least 1 mL. The concentrations of 
antimicrobial agent are generally 2-fold diluted. The broth dilution methods are typically 
used to test pure isolates of non-fastidious aerobic microorganisms, which are easily grown 
by overnight incubation. 
 
Figure 4. Schematic illustration of classic broth dilution AST method for the 
determination of MIC. 
Since the classic broth dilution methods are laborious, the tests have been miniaturized 
and standardized by using broth microdilution [40]. The serial dilution of antimicrobial 
agents is performed in the wells of 96-well plate. Following the inoculation of 
17
2 8 16 32 µg/ml 4
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microorganisms and incubation, as illustrated in Figure 5, the plates are checked for any 
visible microbial growth through the colorimetric or turbidity change.  
 
Figure 5. A representative result of broth microdilution AST method. The picture 
is adapted from the website. https://en.wikipedia.org/wiki/Broth_microdilution 
1.3.1.2 Disk diffusion methods 
Disk diffusion, or Kirby-Bauer test, is one of the classic AST techniques. Due to its 
convenience and low cost, the disk diffusion method is very commonly used for determining 
antimicrobial resistance [40]. In the disk diffusion test, filter paper discs impregnated with 
various pre-defined concentrations of same or different antimicrobial agents are placed on 
an agar plate, which has been pre-swabbed uniformly with pure microbial culture. Next, this 
agar plate is incubated at certain temperature optimal for the growth of a microorganism. 
The incubation time is dependent on the natural growth rate of the tested microorganism. 
During the incubation, the antimicrobial agent diffuses from the disc to the agar. The 
concentration decreases as the distance to the disc increases. If the microorganism is 
susceptible to an antimicrobial agent in the disc, as shown in Figure 6, there is a clear 
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inhibition zone around the disc [41]. In general, the larger inhibition zone correlates to higher 
antimicrobial susceptibility. Therefore, the diameters of the inhibition zones are measured 
to determine the antimicrobial susceptibility. By comparing the reference table provided by 
Clinical and Laboratory Standards Institute (CLSI), the size of inhibition zone indicates 
categorical results (e.g. susceptible, intermediate, resistant) and can be related to MIC [42].  
 
Figure 6. A representative photograph of classic disk diffusion test [41].  
As an alternative method derived from disk diffusion test, Etest is used to provide 
quantitative MIC results. In the Etest, a commercially available thin plastic test strip with 
continuous gradient of antimicrobial agent is placed on an agar plate, which has been pre-
swabbed uniformly with pure microbial culture. Next, this agar plate is incubated. During 
the incubation, as shown in Figure 7, a continuous gradient of concentrations of 
antimicrobial agent is created at the intermediate vicinity of the test strip. The concentration 
gradient remains stable for at least 18-24 hours, which is long enough for most species of 
fastidious and non-fastidious microorganisms. After overnight incubation, a clear ellipse-
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shaped inhibition zone appears along the test strip. The MIC value is read from the scale 
point where the edge of the ellipse intersects with the strip [43].  
 
Figure 7. A representative photograph of classic disk diffusion test [43]. 
As a summary of conventional culture-based AST methods, they are routinely used in 
clinical microbiology laboratories due to the low cost and simple operation. However, the 
typical culturing time (at least 16-24 h) is too long for the clinicians to timely decide the 
most effective antimicrobial therapy. As its consequence, the treatment is generally initiated 
with broad-spectrum drugs, thus facilitating the emergence of “superbugs”. Especially for 
patients with septic shock, initiation of inappropriate antimicrobial treatment results in a 5-
fold decrease in survival [44]. 
1.3.2 Molecular AST methods 
In recent years, more clinical microbiology laboratories are adopting molecular 
approaches, such as nucleic acid amplification techniques [45, 46] and matrix assisted laser 
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desorption ionization time of flight mass spectrometry (MALDI-TOF) [47-49], to accelerate 
the identification of antimicrobial resistance.  
Genotypic methods are based on the detection of specific genes responsible for 
antimicrobial resistance. As the procedures shown in Figure 8, the microorganisms isolated 
from clinical blood or urine samples are lysed and DNA is extracted. Next, the DNA is 
fragmented and the fragments are amplified by nucleic acid amplification techniques, such 
as polymerase chain reaction (PCR) or loop-mediated isothermal amplification (LAMP). 
Targeted genes subject to antimicrobial resistance are identified from the genomic analysis 
[50].  
 
Figure 8. Schematic illustration of general genotypic approach for determining 




Mass spectrometry, particularly MALDI-TOF, is also employed for determining 
antimicrobial susceptibility. The principle is based on the detection of antimicrobial 
resistance related enzymatic activity. For instance, this method detects mass shift 
corresponding to the hydrolysis or degradation of antimicrobial agents in the presence of 
specific enzymes, such as β-lactamase [51, 52] or carbapenemase [53-55]. 
Although molecular approaches are sensitive and fast, they are unable to distinguish live 
and dead cells [56], and the exists of genetic biomarkers do not necessarily correlate to cell 
replication [57]. Furthermore, if new resistance mechanisms arise, they are likely to result 
in false negatives. Therefore, results from phenotypic AST approaches is considered more 
reliable. 
1.3.3 Commercially available AST instruments 
As summarized in Table 1, a variety of commercially available techniques have been 
suggested as candidates for more rapid AST. To reduce labor-cost and human-prone errors 
from the conventional phenotypic methods, several automated instruments, such as BD 
Phoenix, VITEK 2, and MicroScan WalkAway, are used to identify cell growth by tracking 
the colorimetric, fluorescence, or turbidity changes [58, 59]. These instruments are 
established on broth microdilution method, and automated robotics are employed to handle 
standard 96-well microdilution trays. Compared with the manual methods, these instruments 
are able to save significant time and provide accurate quantitative results. Nonetheless, these 
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automated techniques still remain slow due to the low sensitivity of the current detection 
methods.  
As one of the latest commercially available AST techniques, the Accelerate PhenoTest 
BC Kit is able to rapidly identify bacteria within 90 min using fluorescent in-situ 
hybridization (FISH) probes after the cells are isolated from the clinical samples (e.g. blood 
or urine) through gel filtration and electro-kinetically concentrated on a glass substrate [60]. 
The cells are cultured in antibiotic-rich media and imaged by dark field microscopy for 
changes in colony morphology change. The images are analyzed by automated computer 
algorithms and the MIC can be determined within 7 h. 
Another rapid optical imaging-based technique is oCelloScope, which is designed to 
real-time image growth of bacterial cells in a fluid sample using time-lapse microscopy [61]. 
The tilted plane of focus enables scanning of volumes and extraction of phase information. 
Images are then analyzed by an algorithm to render growth curves. MICs can be determined 
within 1-4 h. However, similar as PhenoTest, oCelloScope is unable to image the growth of 
bacteria at single-cell level.  
Table 1. Summary of commercially available laboratory AST methods. 





Turbidity in liquid medium >16 h [62, 63] 
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Disk diffusion Diameter of inhibition zone >16 h [62, 63] 
Etest Inhibition zone generated by antimicrobial 
agent gradient strip 
>16 h [62, 63] 
Flow cytometry Fluorescence from live/dead staining 2-4 h [64] 
PCR DNA amplification of antibiotic resistance 
related genes 
2-4 h [45, 63] 
MALDI-TOF 
MS 
Mass spectra of antibiotic resistance 
related proteins 
1-3 h [48] 
oCelloScope Time lapse imaging of bacterial growth 2-3 h [61] 
BD Phoenixb Colorimetric and turbidity change 8-10 h [65] 
VITEK 2b Transmittance of light due to turbidity  >7.5 h [59] 
MicroScan 
WalkAwayb 
Fluorescence due to metabolism or 
transmittance of light due to turbidity  
4.5-18 h [66] 
PhenoTest BC 
Kitb 
Real-time imaging of bacterial growth <7 h [58, 59] 
aTime for nonfastidious microorganisms 
bFDA-approved automated systems 
1.3.4 Recent advances in rapid AST approaches  
Recently, many innovative modalities have been developed to further shortening the 
time for phenotypic AST. The following is a brief introduction of those innovative 
phenotypic AST methods classified by their working mechanisms.  
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Imaging-based methods  
Methods coupling microfluidics with optical imaging have been reported for rapid AST. As 
depicted in Figure 9, Kwon group demonstrated a microfluidic agarose channel (MAC) 
system, in which bacterial cells were immobilized in agarose by mixing them in the channels 
[67]. Antibiotics were then allowed to diffuse into the system to reach desired concentrations. 
Time-lapse imaging was subsequently conducted on cells in a field of view. The change in 
the total area occupied by the cells over time was analyzed to determine antibiotic 
susceptibility. The MICs, defined in this work as the lowest concentration at which such area 
remains not changed or decreases, were delivered within 3-4 h.  
 
Figure 9. Schematic illustration of microfluidic agarose channel (MAC) system for 
AST [67]. (A) The setup of the MAC system. It consists of a microfabricated 
microfluidic chip with inlets of agarose mixed with bacteria, and culture medium 
containing antibiotics. (B) A mixture of bacteria and agarose was loaded into the 
chip at the center of the setup. After the agarose is solidified, culture medium 
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containing antibiotic was loaded through the channels to reach desired 
concentrations of antibiotic in the agarose gel. Bacterial growth was then monitored 
under a microscope. 
As the derived work of MAC system, imaging-based single-cell morphological analysis 
(SCMA) was further employed for AST based on the analysis of cell morphology change 
and the time-to-readout was less than 4 h [68]. In this system, as shown in Figure 10, MAC 
chip was built in each well of 96-well plate, allowing the system to test multiple 
concentrations of various antimicrobial agents simultaneously. Moreover, the information 
from the images, such as the morphology and growth pattern of microorganisms in the 
presence of antimicrobial agents, can be helpful for the clinicians to identify what would be 
the specific infections. Nevertheless, in this platform, cells were monitored in only one field-
of-view (FOV) (e.g. 0.2mm×0.2mm). Although this approach is able to image bacterial 
growth at single-cell level, considering that antibiotic resistant and susceptible cells coexist 
in clinical samples [69, 70], examining only tens of cells would not be sufficient for a 
convincing conclusion with statistical significance. Furthermore, this method requires a high 
concentration of cells (> 107 cells/mL) to provide enough cell number in such small area. 
Consequently, if the original cell concentration is low, the actual time for AST was extended 





Figure 10. Schematic illustration of imaging-based SCMA system [68].  
To facilitate the diagnosis for patients with infections in bloodstream, Kwon group 
further developed a direct and rapid AST (dRAST) system on the basis of the 96-well plate 
format MAC chip (Figure 11), which can determine the antimicrobial susceptibility of 
bacteria in positive blood culture samples in 6 hours [71]. In general, it requires three times 
of overnight culture, which are blood culture, subculture for bacteria isolation, and AST 
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culture with the addition of antimicrobial agents. As antibiotic-resistant bacteria grow in the 
presence of antibiotics while red blood cells do not, these two types of cells can be 
differentiated using imaging after a few hours of incubation. The advantage of this work lies 
in saving significant time from bacterial isolation and AST culture. However, it is still 
associated with the same low-throughput issue shown in the MAC chip-based AST 
technique.  
 
Figure 11. Schematic illustration of dRAST method [71].  
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Rather than directly imaging bacterial growth, hyperspectral stimulated Raman 
scattering (SRS) microscopy has been developed to image the metabolic activity of bacteria 
at single-cell level to predict the cell viability at the presence of antibiotics [72, 73]. In the 
related studies, as shown in Figure 12, the bacteria were fed with deuterium-labelled glucose 
or water, and signal from C-D vibration was detected to indicate their metabolic activity. 
While SRS microscopy benefits the detection due to its high sensitivity and can provide the 
results within 30 min (typically within a cell cycle), the measured MICs were much larger 
than the results obtained from the traditional culture-based methods, implying that the 
toxicity of deuterium to bacteria cannot be ignored. In addition, it is still challenging to 
enlarge the field-of-view of SRS imaging for improving the throughput. 
 
Figure 12. Schematic illustration of AST based on SRS imaging of bacterial 
metabolic activity [72]. 
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In a study attempting to improve the throughput of tests, a microfluidic platform was 
developed to encapsulate bacteria in droplets (1-4 bacteria per droplet) and track the growth 
of bacteria in each droplet through time-lapse imaging (Figure 13) [74]. As the advantages 
of this platform, the parallelized microfluidic setup can handle multiple tests simultaneously, 
and time-to-answer can be as fast as 15-30 min. However, due to the partition issue, only 
about 20 bacteria can be analyzed from the droplet array. Moreover, quantification of 
bacteria in liquid phase seems to be challenging. 
 
Figure 13. Representative time-lapse images of bacteria in a droplet treated with 
and without antibiotic (a); and normalized bacterial growth rate over time (b) [74]. 
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In another study attempting to improve the throughput of tests, as illustrated in Figure 
15, a microfluidic device containing 2000 channels was designed to trap cells from the fluid 
sample flowing through into the channels, wherein cell divisions along the line of each 
channel were imaged by time-lapse microscopy [75]. The length of the lines over time was 
analyzed to render the growth rate of the cells. Notably, the results can be obtained in less 
than 30 min. Even though this approach is capable of performing single-cell analysis and 
works effectively in testing clinical samples, fixed dimensions of the channels would not be 
able to trap every single cell from those with various size or shape. Moreover, this approach 
would not work for the bacteria that do not grow in filaments in response to antibiotics 
treatment.  
 
Figure 15. Schematic illustration of the microfluidic-based technique for high-
throughput AST [75]. 
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In a recent study attempting to address the limitation of the aforementioned 
microfluidic-based high-though AST technique, Li et al reported an advanced microfluidic 
system capable of testing polymicrobial samples [76]. In the microfluidic system shown in 
Figure 16, bacteria with different shape or size can be trapped in different regions according 
to the applied pressure, which dynamically adjusts the size of channel. Antibiotic 
susceptibility can be determined in 30 min by using optical imaging to monitor the growth 
of bacteria at single-cell level. The innovation of this work is based on the automatic 
separation and classification of bacteria, allowing direct analysis of clinical isolates, blood 
cultures, urine, and whole blood samples. However, this technique requires highly 
sophisticated engineering, attenuating its general applicability for clinical use.  
 
Figure 16. Schematic illustration of adaptable microfluidic device for bacteria 
classification and AST at single-cell level [76]. 
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Recently, machine learning or deep learning was also employed to detect the increase 
in the cell number from a video of fluid cell culture medium with the addition of antibiotics 
(Figure 17) [77]. By training algorithms with large amount of data collected from the 
experiments, machine learning is able to provide the number of cells freely moving in a 
liquid sample by defining and quantifying multiple phenotypic features, such as rotation and 
motion in liquid sample, that traditional 2D image processing algorithms cannot perform 
[78]. As a powerful method, the results can be obtained within 30 min from an artificial urine 
sample. However, machine learning for AST is also limited by the programming platforms, 
as well as the reliance on large sets of clinical data collection. For example, this platform 
may not be effective on rapidly identifying antimicrobial resistance from an infection caused 
by a new bacterial species. 
 




With the developments in micro- and nanofabrication, several AST platforms have been 
established using microcantilevers [79-82]. The sensing of bacteria relies on selectively 
capturing cells by the receptors immobilized on the cantilever surface and translating the 
binding into mechanical signals as cantilever deflection (static mode) or a shift in resonance 
frequency (dynamic mode). As recently reported mechanical sensors shown in Figure 18, 
microcantilevers coupled with microfluidics were used for AST by measuring the single-cell 
growth rate based on mass change, which corresponded to the resonance frequency [80]. 
The advantages of this technique are the high sensitivity on detection of nanoscale 
fluctuations associated with mass change and rapid differentiation of antibiotic resistant and 
susceptible bacteria in less than 30 min. However, only up to 150 bacterial cells can be 
monitored per hour, attenuating its applicability for high-throughput detection.  
 






Despite significant advances in electrochemical biosensors for AST, a majority of 
available methods were established on the indirect indication of bacterial growth by 
detecting redox reporters of cell metabolism [83-86]. Metabolically-active bacteria reduce 
the redox reporter compounds, such as resazurin or methylene blue, and the changes in the 
redox state of the reporters are detected by electrodes. Since the redox reporters are not 
pathogen-specific, recent studies have focused more on isolating the bacteria directly from 
the sample first and performing label-free detection. As an example, Safavieh et al. 
immobilized bacterial cells on an electrochemical sensing chip with screen-printed 
electrodes and measured the change of impedance as cells grow for rapid AST [87]. This 
approach can provide readouts for whole blood samples in 90 min. Although the impedance 
sensors are advantageous in their simplicity, non-specific binding is considered as a common 
issue. Furthermore, it is also not clear if the electrical signal is affected by bacterial 
morphology change or if the bacterial growth is affected by the electrical current.  
Summary of recent advances in rapid AST approaches 
As summarized in Table 2, based on the working mechanisms, recently emerged 
platforms for rapid AST can be classified into direct observation of microbial growth through 
microscopy imaging and indirect sensing microbial growth through the change in physical 
characteristics, such as mass or impedance. The significant advance is that the time for AST 
has been shortened to several hours or even less than one hours. In my opinion, since the 
detection of the subtle changes of physical characteristics is prone to render false positive, 
microscopically visualizing the microbial cell divisions would be the most straightforward 
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method to indicate the antimicrobial resistance at single-cell level. However, as the major 
drawback of microscopy imaging Although coupling the microfluidic techniques with 
microscopy imaging has allowed high-throughput AST, the incorporation of external circuits 
and pumps to maintain the flow continuity in the system requires sophisticated engineering, 
thus increasing the cost. Therefore, rapid and low-cost microscopy imaging-based AST 
methods are still highly demanded. 
 




Table 2. A summary of recent advances in rapid AST approaches. 
AST technique Measurements Time Throughput References 
MAC chip Bacterial growth 3-4 h Low [67] 
SCMA chip Bacterial growth and 
morphological pattern 
< 4 h Low [68] 
dRAST Proliferating bacteria 
in blood culture 





along the channel 
< 30 min High [75] 
Adaptable 
microfluidic device 
  High [76] 




Number of cells < 30 min  [77] 
SRS imaging* Metabolic activity < 30 min Low [72] 
Microcantilever 
mass sensors* 





Impedance 90 min  [87] 
* AST methods that indirectly detect antimicrobial resistance. 
1.4 Motivation, research objectives, and organization  
1.4.1 Motivation 
It is known that the conventional and commercial culture-based AST techniques are 
established on monitoring the cell growth by the change in their population. As single 
microbial cells vary widely in their growth rates and the subpopulation that grow faster 
dominate the overall growth rate, analyzing single-cell growth rate would benefit in 
facilitating the detection by identifying the rapidly growing subpopulation at the earliest 
stage. Moreover, antimicrobial-resistant and -susceptible cells generally co-exist in the 
clinical samples, emphasizing the necessity to respect the biological heterogeneity. As 
described in the introduction, several microscopy imaging-based techniques are capable of 
monitoring single-cell growth, but they are limited to low throughput, resulting in no 
statistical significance in addressing the biological heterogeneity. As the microfluidic-based 
platform shows high-throughput ability, it is not generalizable to the cells that vary in cell 
size, shape, and growth pattern. In the dissertation projects, to tackle the challenges that the 
area of a single FOV of microscopy imaging is so small, we aimed to employing whole slide 
imaging (WSI) to enlarge the FOV, visualize and track the growth of a large population 
bacteria. WSI, a technique that composites numerous tiles (each tile is a single microscopic 
FOV) captured from a specimen on a glass slide into one image, has been exploited in a 
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variety of biomedical applications, such as whole-slide histopathology analysis. Nonetheless, 
to our knowledge, few studies have investigated the potentials of WSI in AST. If this concept 
works, this technique would be able to high-throughput monitor microbial growth at single-
cell level, regardless their size, shape, or growth pattern. Furthermore, it can also be 
employed to evaluate a phenotypically heterogenous sample, in which the antibiotic resistant 
subpopulation is significantly small. This would be of benefit in monitoring the frequency 
of rising antibiotic resistance during the treatment and timely adjusting the antibiotic 
treatment regimen to avoid further aggravation of the drug resistance.  
1.4.2 Research objectives 
First, we aimed to develop a microbial culture system, which is compatible with whole 
slide imaging. This system was expected to render images with large FOV, wherein every 
individual cell is in focus. The previously reported methods for the preparation of 
microscopy sample slides are suitable for imaging the growth of only one live cell from a 
single FOV [88-90]. Limited by specific purpose, those methods did not require the gel pad 
to be very flat. Therefore, our aim was to customize microscope slides, in which the gel pad 
should be flat enough for imaging a large population of cells.  
Second, we aimed to time-lapse image microbial growth at single-cell level using the 
microbial culture slides customized for whole slide imaging. If necessary, microscope with 
autofocus function would be applied to ensure every individual cell is in focus.  
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Third, we aimed to perform antimicrobial susceptibility testing using our microscope 
culture slides customized for whole slide imaging. To evaluate the performance of our 
system, bacteria, fungi, and phenotypical heterogeneous samples were to be tested.  
1.4.3 Organization 
In Chapter 2, we describe the development of microbial culture slides compatible with 
whole slide imaging. To identify if the surface of agarose gel pad is flat enough, we first 
evaluated the performance of our microscope culture slides through the enumeration of the 
bacterial micro-colonies.  
In Chapter 3 and 4, we introduce a WSI-based AST approach, which is capable of 
determining antimicrobial susceptibility of bacteria, fungi, and phenotypical heterogeneous 
samples by monitoring the growth of a large population of single cells. 
In Chapter 5, the projects present in this dissertation is summarized. Based on the 
advantages and limitations of our AST technique, the potential applicability of this technique 









Development of Custom-Built On-Glass-Slide Microbial 
Culturing System for Whole Slide Imaging  
2.1 Introduction 
In microbiological research, it is essential to accurately enumerate microbial cells. For 
example, as a key step in developing new antimicrobial agents, the determination of 
minimum inhibitory concentration (MIC) requires inoculation of precise number of viable 
microorganisms [39, 42]. To date, colony-forming unit (CFU) has been used as a gold 
standard method for estimating the number of viable microbial cells [91]. In this 
conventional method, liquid microbial suspension is uniformly spread on the surface of 
semi-solid nutrient agar plate by an inoculation loop. Next, the plate is incubated at an 
optimal temperature until the cells grow to visible colonies [92, 93]. The number of colonies 
is referred to as CFU. 
As major advantages of agar plate method, the materials are inexpensive and the 
procedures are simple enough for trainees to follow. However, long cell culture time (up to 
a few days) and laborious manual counting result in poor time and cost efficiency [91]. To 
reduce manual work and its related human error, commercial automated colony-counters, 
such as ProtoCOL (Synbiosis, UK), have been established through applications of imaging 
processing algorithms. Nonetheless, the counting results are accurate only when the number 
 
 35 
of colonies per plate is between 10 and 200 [94]. Thus, serial dilutions of microbial samples 
are necessary to ensure a countable range. As a major concern of serial dilutions, errors 
become larger as dilution times increase or total counts per plate decrease [95]. 
To address the shortcomings of the conventional method, counting invisible growing 
micro-colonies (average radius <100 microns) at the very early stage of culturing provides 
a potentially alternative tool [96-99]. On one hand, it enables much faster detection of viable 
microbial cells by significantly shortening cell culture time. On the other hand, considering 
the large difference in size, same culture area can accommodate a lot more micro-colonies 
and thereby reduce dilution-induced errors. These previous attempts can be classified into 
using lensless techniques and conventional light microscopy. Recently, Jung et al. employed 
a complementary metal-oxide-semiconductor (CMOS) sensor chip to real-time image the 
microbial cells growing into micro-colonies and demonstrated that micro-colony-based 
enumeration results were comparable to conventional method [97]. However, the non-
movable small imaging area (5.7 mm × 4.3 mm) and limited sample loading volume (1 µL) 
failed to exceed the cell capacity of agar plate. Moreover, limited nutrition and air in their 
isolated cell culture setup resulted in delayed growth of aerobic bacteria, which would not 
significantly shorten the detection time. Hence, this on-chip imaging technique seemed not 
to overcome the limitations faced by the conventional counting method. Compared to the 
lensless imaging systems, conventional light microscopy can deliver higher resolution of 
images with clear morphology and contrast of the micro-colonies [90]. Although field-of-
view (FOV) of each image captured by microscope is very small, microscope is capable of 
producing a large image in any desired size by stitching numerous images taken from the 
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culture area of interest [100]. In previous studies, wide-field fluorescence microscopy was 
employed to rapidly enumerate micro-colonies stained by fluorescent probes, which served 
as viable cell indicators [96]. However, the counts from microscope could be 50 times larger 
than those from conventional method [96]. In addition to the interference caused by light 
scattering, lacking of solid data of accuracy validation restrained microscopy-based counting 
techniques from broader applications. 
In this study, we demonstrated a novel microscopy-based viable bacteria enumeration 
technique that employed large-area microscopic scanning to achieve rapid, accurate, and 
label-free enumeration. Specifically, we first developed a bacteria culturing device for 
microscopic scanning. This device enabled rapid formation of micro-colonies on a 0.38 mm-
thick gel film without suffering from nutrient and oxygen deprivation. Next, an imaging 
setup was customized for rapid automated scanning of the micro-colonies. As a 
demonstration, EGFP-expressing E. coli was used to evaluate the performance of the 
bacteria culturing device and the imaging setup. Herein, a modified confocal microscope 
with a motorized x-y sample holder plane was employed to scan the sample area and create 
phase contrast and fluorescence images side by side. Using fluorescence as a reference, 
automatically counting the micro-colonies in the phase contrast image was able to accurately 
provide the number of them. More importantly, this technique not only shortened the 
culturing time to within 5 hours, but also allowed the labor-intensive plate counting work to 
be automatically conducted on a glass slide, thoroughly overcoming the limitations of the 
conventional method.  
2.2 Materials and Methods 
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2.2.1. Materials and Instruments 
Luria-Bertani (LB) broth for growing bacteria was purchased from Sigma-Aldrich. 
Agarose was from Promega. Silicon wafer was obtained from University Wafer (Boston, 
MA). Agar, polystyrene petri dishes (diameter 100 mm), glass microscope slides and 
coverslips were purchased from Thermo Fisher Scientific. Escherichia coli (E. coli) K-12 
expressing enhanced green fluorescent protein (EGFP) was received as gift from Dr. Yongku 
Cho’s laboratory (University of Connecticut). The fluorescence from E. coli expressed 
EGFP was used only for validation purpose. Images were captured by Nikon A1R confocal 
microscope (Nikon, Japan) and processed using Nikon NIS Elements AR 4.40 software.  
2.2.2. Preparation of On-Glass-Slide Bacteria Culturing Device 
A microscope glass slide with two pieces of spacers (0.38 mm-thick silicon wafer) on 
the top of it was placed in a petri dish. Another piece of cover glass slide was then mounted 
on the silicon wafers to form an empty chamber between the two glass slides. Next, 2% (w/v) 
LB culture media and 0.6% (w/v) agarose were suspended in deionized water. This mixture 
was sterilized by autoclaving at 121 °C for 15 minutes. When the media cooled down below 
60 °C, kanamycin was added to a final concentration of 50 µg/mL for the selection of EGFP 
expression. This molten medium was poured into the petri dish and filled the empty chamber. 
After the media was kept at room temperature for 20 minutes and became solidified, the 
cover glass slide was gently removed to present a thin film of nutrient gel with flat surface.  
2.2.3. Preparation of Bacterial Samples 
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The cell culture media, 2% (w/v) LB broth was prepared by dissolving 2 g of LB powder 
(a mixture of 1 g tryptone, 0.5 g yeast extract, and 0.5 g sodium chloride) in 100 mL 
deionized water. Since E. coli cells carried antibiotic resistant gene as a reporter of the 
production of EGFP, kanamycin was added to a final concentration of 50 µg/mL for the 
selection of EGFP expression. E. coli cells from the stock were inoculated into LB broth and 
pre-enriched at 200 rpm in a 37 °C shaker for 4 hours to ensure the bacterial growth was at 
log phase. Then, the cells were diluted into various concentrations of interest with phosphate 
buffered saline (PBS). Bacterial suspension (5 µL) was dropped onto the aforementioned 
thin film of LB-agarose gel. After the drop completely evaporated, the petri dishes were 
transferred into a 37 °C incubator. The surface of culture area was placed upside down to 
prevent the loss of water content. 
2.2.4. Imaging Bacterial Micro-colonies using Microscopic Scanning 
After a 5-hour incubation, the glass slide with the thin film was taken out by cutting off 
the surrounding bulk of LB-agarose gel. Then, the silicon wafer spacers were removed and 
a glass coverslip was gently mounted on the cell culture area that carries micro-colonies. To 
ensure the distance between the micro-colonies and the lens constant, the coverslip side of 
the gel was mounted on a supporting glass slide. This setup was next placed on the motorized 
x-y sample holder stage of confocal microscope, where the supporting glass slide was at the 
bottom (Figure 2A). After the horizontal plane of micro-colonies was focused by the 
objective lens, images were continuously captured as the sample holder stage moved along 
a sequential path programmed by the control panel of Nikon software until the entire sample 
area was scanned (Figure 2C). Herein, tiles of phase contrast and fluorescence images (0.665 
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mm × 0.665 mm for each tile) were acquired simultaneously by an S Plan Fluor ELWD Ph1 
20× objective lens (NA 0.45, Nikon, Japan). Finally, the Nikon NIS Elements software 
automatically created a large image by stitching all the tiles together.  
2.2.5. Image Processing and Micro-colony Enumeration  
The large image obtained from the confocal microscopic scanning was analyzed by 
using ImageJ software (NIH, USA). First, the threshold was adjusted to enhance the contrast 
of the objects of interest. Second, the image was binarized to remove the noise by rendering 
micro-colony regions with clear boundaries as black and surrounding background as white. 
After the binarization, filling-holes processing was conducted to ensure each closed region 
represents one intact micro-colony. Finally, micro-colony regions above desired size were 
outlined and the number of these regions was automatically counted by ImageJ software. An 
example of image processing is described in detail in Figure 5.  
2.2.6. Bacteria Enumeration using Conventional Agar Plate 
A sterile molten liquid mixture of 2% (w/v) LB culture media and 1.5% (w/v) agar 
supplemented with 50 µg/mL kanamycin was poured into petri dishes. As a gelling reagent, 
the agar can be replaced by agarose and the concentration of it can be adjusted according to 
specific need. After the media was solidified in 20 minutes, 100 µL of E. coli suspension 
was inoculated onto the surface of the gel by uniformly spreading it using a metal loop. The 
petri dishes were then incubated at 37 °C. After the bacterial colonies were detectable by 
naked eyes, the number of colonies was manually counted. 
2.3 Results and Discussion 
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2.3.1 Preparation and Evaluation of On-Glass-Slide Bacteria Culturing Device 
In previous studies, micro-colonies were grown and imaged on a film of nutrient gel, 
which had to be thin enough to deliver good transparency and thereby generate high-quality 
images. To prevent the thin gel film from drying out, it was sealed in a closed chamber 
during cell culture and imaging [90, 97]. However, limited nutrition and isolating oxygen 
supplies resulted in slow cell growth. To address this issue, we invented a special on-glass-
slide bacteria culturing device (details of preparation is described in Experimental Section). 
As illustrated in Figure 1A, a glass slide was embedded in LB-agarose gel. On the top of the 
glass slide was a flat thin gel film, whose thickness (0.38 mm) was determined by that of the 
spacer. The cross-section of this device (Figure 1B) shows that the thin film is like a “bridge” 
connected the bulk gel. This unique design ensures that the film can continuously receive 
water and nutrition from the bulk gel, as well as oxygen from the ambient air, allowing long 
time incubation without gel drying and rapid formation of micro-colonies without suffering 




Figure 1. Schematics of the reported custom-built on-glass-slide microbial 
culturing device. (A) A thin LB-agarose gel film with flat surface created on a glass 
slide in a petri dish. The components of the device are described. (B) A cross-
section of the device showing its capability of culturing microorganisms on the thin 
gel film without any growth limitation.  
Regarding the composition of the semi-solid culture media, there was only one 
difference between our system and the conventional method. Here, we used agarose instead 
of agar to prepare the nutrient gel. Typically, agar is added to aqueous nutrition to form gel 
matrix, which helps immobilize microbial cells and support them to multiply to colonies. 
However, the opaque appearance of agar gel determines that it is not a good choice for 
imaging application [101]. As an alternative, agarose gel has been extensively employed for 
imaging due to better optical clarity [67, 72, 90, 97, 102-105]. Notably, the flatness of the 
gel surface is critical for acquirement of high quality scanning image and the accuracy of 
micro-colonies counting. Hence, we prepared the gel matrix using 0.6% (w/v) agarose rather 
than widely used 1.5%, since it was difficult to generate flat thin gel film when the agarose 
concentration was above 0.6%. Even though the gel becomes softer as agarose content 
decreases, as previously reported, 0.6% agarose or agar gel still possessed good ability to 
immobilize microbial cells and support their growth without any issue [103, 106].  
To evaluate the cell-cultivability of this device, we inoculated same amount of bacterial 
suspension on LB-agarose thin film, conventional LB agar (1.5%) plate, and LB agarose 
(0.6% and 1.5%) plate respectively and monitored the growth of bacteria. Since inoculation, 
pictures of these LB agar/agarose plates were captured at 0, 8, 11, 13, 15, and 17 hours. It 
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was observed that the bacterial colonies became visible to naked eye and manually countable 
at 13 hours. The average size of the colonies from these methods showed no remarkable 
difference (Figure 2), suggesting that the cells on our custom-designed thin gel film grew as 
fast as on conventional agar plates. Therefore, microscopically analyzing the invisible 





Figure 2. Representative images of bacterial colonies on LB-0.6% agarose thin film 
in the custom-built device (A), LB-0.6% agarose petri dish plate (B), LB-1.5% agar 
petri dish plate (C), and LB-1.5% agarose petri dish plate (D). The images were 
captured after 13 hours incubation at 37 °C. Scale bars: 2 mm. 
2.3.2 Microscopic Scanning Micro-colonies on a Large Sample Area  
Since bacteria cells are transparent in reality and do not affect the amplitude of visible 
light waves passing through them, high-contrast images are needed for recognizing them. 
Presented in Figure 3 are images of E. coli micro-colonies captured in phase contrast and 
DIC, respectively. Obviously, compared to DIC, it is much easier to utilize phase contrast to 
distinguish the micro-colonies from the background. Moreover, a halo surrounding each 
micro-colony indicates the boundary and further benefits the identification. Therefore, it is 











Figure 4. Schematic illustration of the reported micro-colony imaging system. (A) 
a photograph of the experimental setup. (B) The components of a sample setup. The 
thickness of each component is described. (C) The scanning of the entire cell 
culture area on thin LB-agarose gel film is conducted by sequentially capturing 
images in field-of-views. Each square on the plane represents a field-of-view. The 
arrows indicate the path of the movement of the camera.  
Aiming at recording all the micro-colonies in one image, we employed microscopic 
scanning technique to generate an image encompassing the entire sample area. Such 
scanning was conducted by continuously capturing tiles of images on certain focal plane and 
stitching the tiles together into a large image. Considering bacterial micro-colonies growing 
on gel matrix actually expand in three dimensions [107] and their thickness may not be 
uniform, significantly more time would be consumed on locating each object through 
continuously focusing at different depths in the z-direction. To enable fast imaging, we 
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customized the sample setup to ensure that all the micro-colonies could be scanned without 
conducting any z-scanning. As illustrated in Figure 4B, the setup consisted of a glass slide 
on the top, a gel film in the middle, a coverslip and a supporting glass slide on the bottom. 
The micro-colonies at the bottom side of the gel film were compressed on the coverslip by 
the gravity of the glass slide on the top. The robust flat surface of the supporting glass slide 
rendered a horizontal coverslip-gel interface, which could be considered as a perfect target 
plane for the scanning. Moreover, the thickness of the coverslip and supporting glass was 
fixed, assuring that the distance between the target plane and the lens remained constant. 
Hence, no concern about any out-of-focus issue was expected. 
To test the performance of this system, we used EGFP-expressing E. coli as a model 
bacterium and conducted scanning of the micro-colonies grown from them. Although 
bacteria cells in reality are seldom fluorescent, the green fluorescence from micro-colonies 
was merely used as a reference to corroborate the accuracy of the result obtained from phase 
contrast images. Herein, we chose confocal microscopy to meet the specific need of both 
phase contrast and high-quality fluorescence images in this study. As the LB-agarose gel is 
a thick specimen with considerable autofluorescence, the confocal microscope can block the 
out-of-focus light above and below the focal plane by the spatial pinhole and therefore 
provides higher resolution and enhanced contrast by increasing signal-to-noise ratio [108-
110]. Additionally, since the transmitted light mode of confocal microscopy can also view 
specimen through phase contrast [111], confocal microscopy is capable of simultaneously 
generating high-quality fluorescence and phase contrast images and viewing them side by 
side, whereas this cannot be achieved by other microscopy. However, it is worth noting that 
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confocal microscopy is not required for real applications if only phase contrast is employed 
in enumeration of viable microorganisms. After the bacteria cells on thin gel film were 
incubated at 37 °C for 5 hours, the culture area was scanned at a speed of approximately 
17.7 mm2/min by a 20× objective lens. Figure 5 displays a large image (1.16 cm × 1.81 cm) 
created by stitching tiles of images together. The area was large enough to accommodate all 
the micro-colonies. Zooming in the large image enabled us to identify each micro-colony by 
phase contrast or fluorescence. It was clear that the micro-colonies presented on the 
boundaries between the tiles were in their normal shape, suggesting that there was no 
stitching artifact, such as duplication or disappearance. Therefore, the large image 






Figure 5. Representative images captured by using the reported platform. 
Transmitted light (A) and fluorescence (B) images of bacterial micro-colonies 
presented on an area of 1.16 cm × 1.81 cm. Fluorescence image was only used for 
confirmation purpose. 
2.3.3 Micro-colony Enumeration 
After the images were acquired by confocal microscopy scanning, the micro-colonies 
appeared there were enumerated by using image-processing software. Figure 6A presents a 
selected area containing micro-colonies grown from the cells in 5 µL bacterial suspension. 
In addition to micro-colonies, empty regions that could be produced by artifacts or tiny air 
bubbles were also shown in the image. Nonetheless, these objects do not cause any 
interference in recognizing the micro-colonies. It is known that phase contrast is generated 
by the difference in density. Since no other elements, such as the empty regions, throughout 
the imaged area were as dense as the micro-colonies, micro-colonies can be easily 
distinguished by filtering the objects with low contrast. Figure 6B shows the corresponding 
processed image, in which the total number of micro-colonies (dark regions) was counted as 
155 (details of the algorithms applied in automated enumeration are described in Figure 7). 
The locations of the micro-colonies and the number of them were consistent with those 
obtained from the fluorescence image (Figure 6C), indicating that the result obtained from 
phase contrast image was trustworthy. To validate if this result represented actively growing 
micro-colonies, the imaged sample was placed back into the agar plate and further cultured 
in situ for 20 hours at room temperature until visible colonies appeared. The image of these 
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visible colonies (Figure 6D), which was captured by a Nikon D5300 DSLR camera (Nikon, 
Japan), was used to compare with that of micro-colonies side by side.  
 
Figure 6. Phase contrast (A) and fluorescence (B) images of an area (7.9 mm × 9.0 
mm) containing micro-colonies grown from the inoculated cells in 5 µL bacterial 
suspension. Scale bars: 500 µm. Fluorescence image was only used for 
confirmation purpose. (C) An image processed from the raw image in (A). The 
black spots indicate micro-colonies. (D) A photograph of visible colonies in situ 
developed from the micro-colonies shown in (A) and (B). The whitish dots were 
 
 49 
bacterial colonies. The objects pointed by the white arrows were debris, which can 
be distinguished from the bacterial colonies by the colors. The difference in color 
can be more easily identified from the high-resolution photograph shown in Figure 
8. 
Apparently, all the micro-colonies were capable of actively growing, indicating that the 
number of micro-colonies certainly represents that of viable microbial microorganisms. 
Furthermore, we found that, multiple micro-colonies in close proximity to each other, which 
could eventually develop to one single visible colony under the conventional agar plate 
enumerating method, can be identified and differentiated microscopically using our method. 
For instance, colony 1 was derived from one micro-colony, whereas colony 2 was developed 
from three neighboring micro-colonies. This finding suggests that, especially when the 
density of cells inoculated on an agar plate is high, the counts obtained from the conventional 
method are much likely to be underestimated. By contrast, our digital enumeration technique 
can differentiate the neighboring micro-colonies at the earliest stage and be more accurate 
than counting large visible colonies used in conventional methods. According to specific 
needs, the upper counting limit can be increased by simply expanding the scanning area. 
This feature allow that fewer or even no dilutions are needed using our enumerating method, 
which could reduce the serial dilution-induced error. Furthermore, enumerating around 200 
micro-colonies within an area of 60 mm2, which is the maximum limit of a 100 mm agar 
plate, took only around 3 minutes, freeing up more space and workload on sample 
preparation through miniaturizing the work on a piece of glass slide. It is worthy of noting 
that the scanning time was limited by the function of confocal microscopy. In this study, 
 
 50 
confocal microscopy was only used to evaluate the performance of our custom-designed 
bacteria culturing and imaging system in the compatibility with the microscopic scanning 
function. In practice, since the technique reported here can accurately deliver the counts of 
micro-colonies only from phase contrast images (fluorescence imaging is not necessary), 
some recently emerged ultrafast high-resolution microscopic scanning techniques [112-
114], which can conduct whole glass slide scanning in a few minutes, would be able to 
further reduce the scanning time per unit area and thereby provide counting result in a timely 




Figure 7. An example of automated enumeration of micro-colonies. The original 
transmitted light image (A) was processed through adjusting threshold (B), finding 
edges, binarization, and filling the holes (C), and the black regions above certain 






Figure 8. The original photograph of visible colonies shown in Figure 4D. The 
whitish dots were bacterial colonies. The objects pointed by white arrows were 
debris, which can be distinguished from the bacterial colonies by the colors. 
2.4 Conclusions 
We demonstrated a unique technique that enabled digital, rapid, accurate, label-free 
enumeration of viable microorganisms using optical scanning microscopy. A custom-built 
bacteria culturing and imaging system was applied to ensure that all the micro-colonies on 
the large sample area could be displayed on an image generated by microscopic scanning. 
Since the micro-colonies can be counted based on their phase contrast rather than fluorescent 
staining, the procedures are much simplified, rendering this technique applicable to a wide 
range of microorganisms that can form micro-colonies with clear edges. Employing E. coli 
as a model bacterium, our method reduced the cell culture time from at least 13 hours 
required for the conventional method to within 5 hours. Compared to conventional 
enumerating methods requiring an overnight (18-24 hours) incubation, such improvement 
would benefit the analytical methods that require rapid and accurate quantitative 
determination of bacteria. Moreover, since the employment of confocal microscopy proved 
that this enumeration system was compatible with the microscopic scanning function, the 
application of cost-effective ultrafast microscopic scanning techniques in the future would 
significantly enhance the performance of our system by miniaturizing the bacteria 
enumeration work with hundreds of agar plates into a piece of microscope glass slide. 
Notably, regarding the quantification of viable bacteria, this method is more accurate than 
the conventional agar plate method due to the fact that neighboring bacteria before merging 
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into one large visible colony can be differentiated using our method. Therefore, this 
microscopic scanning-based micro-colony enumeration system has great potential for being 



















Whole Slide Imaging for High-throughput Monitoring 
Bacterial Growth at Single-Cell Level and Its Application 
to Rapid Antibiotic Susceptibility Testing 
3.1 Introduction 
Due to the overuse and misuse of antibiotics, the increasing emergence and spread of 
antibiotic-resistant bacteria in human infections, such as MRSA,VRE, ESBL- and 
carbapenemase-producers, has become a global threat to public health [8, 115-119]. 
Unfortunately, the lacking of newly developed antimicrobial agents has been worsening the 
crisis [120, 121]. To reduce inappropriate use of antibiotics, antibiotic susceptibility testing 
(AST) is employed by healthcare providers to guide the prescription of antibiotics. The most 
widely accepted AST methods, such as broth/agar dilution and Kirby-Bauer disk diffusion, 
are based on the observation of visible bacterial growth in the presence of antibiotics [40]. 
These conventional methods are routinely used and cost-effective, but they typically require 
at least 24-72 h for reliable readout [122]. Such delay leads to empirical use of antibiotics 
and consequent increase in mortality [123, 124]. Especially for patients with septic shock, 
initiation of inappropriate antimicrobial treatment results in a 5-fold decrease in survival 
[44]. An alternative AST approach relies on the detection of specific genes or proteins 
responsible for antibiotic resistance by molecular techniques, such as polymerase chain 
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reaction (PCR) and mass spectrometry [46, 47, 125-129]. Although molecular methods are 
sensitive and fast, the existence of biomarkers do not always correlate to phenotypic 
antibiotic resistance [130]. Furthermore, if new resistance mechanisms arise, they are likely 
to result in false negatives [131]. Thus, rapid AST techniques without compromising 
accuracy are urgently needed. 
To date, a plethora of innovative approaches have been developed to shorten the time 
for AST to a few hours or less [50, 132]. Particularly, several platforms employed 
microfluidics, optical imaging techniques, or mass sensor arrays to determine antibiotic 
susceptibility by monitoring single-cell growth [67, 68, 71, 74, 75, 80]. Considering that 
antibiotic resistant and susceptible cells coexist in clinical samples [69, 70], apparently, 
detecting the rapidly multiplying individuals in a background of dying cells would take much 
less time than assays monitoring population growth. Thus, single-cell AST techniques would 
be more applicable for point-of-care tests. Nevertheless, since bacterial cells vary largely in 
their growth rates, the ability of available single-cell AST methods in providing precise 
results with statistical significance is hindered by low throughput. In a recent study, the 
throughput was significantly improved by analyzing the growth rates of thousands of single 
cells confined in microfluidic channels [75]. Although the concept introduced in this work 
is elegant, as clinical samples are typically polymicrobial and even genetically identical cells 
vary in size and shape [133-135], fixed dimensions of the channels would not be able to trap 
every single cell with various size and shape, thus losing potentially useful data concerning 
biological heterogeneity. In addition, since cells were confined to proliferate in only one 
direction, and the ability of each cell to overcome the external restriction may vary, detection 
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of growth rate using this method might not be as accurate as the results obtained from free-
growing cells. 
Here, we report a novel single-cell AST technique based on whole slide imaging (WSI) 
technique. Capable of digitizing a specimen on a glass slide into a single image, WSI has 
been extensively exploited to image histopathology slides for diagnostic use [136-138]. 
However, to our knowledge, the applications of WSI in AST have not been reported yet. In 
this study, WSI was employed to expand the imaging area, thereby allowing the visualization 
of a large population of cells regardless of their biological heterogeneity. As a demonstration, 
we conducted time-lapse imaging of thousands of E. cloacae cells in a WSI-compatible 
bacterial culturing glass slides that we previously reported [139] to track single-cell growth. 
Antibiotic susceptibility profiles of E. cloacae against gentamicin was determined by high-
throughput analyzing single-cell growth rate. Moreover, to address the advantage of the 
significant improvement in throughput, our technique was applied to determining antibiotic 
susceptibility of an artificial phenotypically heterogeneous sample, in which the number of 
antibiotic resistant cells was negligible compared to that of the susceptible cells. For 
validation purposes, results obtained from our method were compared with the gold standard 
broth dilution method. 
3.2 Results and Discussion 
3.2.1 WSI-based monitoring bacterial growth at single-cell level 
To obtain an image encompassing a large population of single cells, “sandwich” slides 
with great bacterial cultivability that we previously customized for WSI was employed 
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[139]. As illustrated in Scheme 1, this system consists of a cover glass on the top, a 
supporting glass at bottom, and a 0.38 mm-thick gel pad with good optical transparency in 
between. Bacterial cells are immobilized on the interface between the gel and the supporting 
glass. Notably, owing to the “sandwich” structure and refined composition of the gel, the gel 
pad is robust enough and tightly adhered to the supporting glass to avoid any deformation or 
sliding during WSI. Next, phase contrast images of the entire sample area were acquired as 
the sample stage moves and seamlessly stitched together into one image. 
 
Scheme 1. Schematic illustration of the preparation of the “sandwich slides” for 
bacterial culturing and whole slide imaging. 
To test the performance of this system, we conducted WSI to image E. cloacae cells 
deposited into the “sandwich” slides. Considering that the bacteria cells are small and might 
not sit on the same focal plane, rapid autofocus technology was applied to minimize out-of-
focus issue. As a demonstration, Figure 1 displays a composite image of a sample area (8.48 
mm ´ 7.69 mm). Zooming in the image enabled the visualization of individual cells, which 
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were all in-focus. Herein, using a 40´ objective lens, the imaging took only 3.5 min. 
Considering that the natural doubling time of bacteria is ~20 min and even longer during 
antibiotic treatment, it was assumed that there was no significant change in cell size during 
such fast imaging.  
To employ this system to monitor single-cell growth, the “sandwich” slides were 
incubated at 37 °C and a humidity of 90%, under which condition the dimensions of the gel 
pad were not changed. Subsequently, time-lapse imaging was conducted on the same sample 
area at 15, 30, 45, and 60 min. After the composite images were collected, they were 
processed by ImageJ software and converted into binary format images, in which the cells 
were black and background was white. Since each composite image was in gigabytes, we 
selected a small subarea containing 9 cells as a demonstration of analyzing single-cell growth 
(Figure 2). To quantify the bacterial size, the area occupied by a single cell or the 
corresponding microcolony developed from it was measured from the processed images. 
Since there was no significant drifting of the x-y coordinates while the bacterial cells were 
growing, the areas with matched coordinates represented a group of bacteria originated from 
the same cell. For each individual cell, the normalized growth rate at time t was calculated 
using equation (1), where At and A0 are the areas originated from the same cells at time t and 
time 0, respectively. Depicted in Figure 3 are the growth rate curves of 9 cells. Apparently, 
at each time point, the variation of the growth rates was large, emphasizing the necessities 
of analyzing a large population of cells for accurate determination of antibiotic susceptibility 








Figure 1. A representative composite image captured by the reported platform. 




Figure 2. Time-lapse images of one representative area selected from the 
composite image in Figure 1 and corresponding post-processing binary images. 
Scale bar, 5 µm.  
 
Figure 3. Single-cell growth rate of bacterial cells presented in Figure 2.  
3.2.2 Determination of minimal inhibitory concentration (MIC) by WSI-based AST 
To investigate the ability our method to determine antibiotic susceptibility, we 
performed tests through tracking single-cell growth of E. cloacae in response to gentamicin 
treatments, which is illustrated in Scheme 2. Herein, the tested concentrations of gentamicin 
in gel pad were 2, 4, 8, and 16 µg/mL and the number of cells treated at each antibiotic 
concentration were 3964, 4387, 5199, and 5778, respectively. The populations were 
sufficiently large to show statistically significance in addressing the biological 
heterogeneity. Based on the analysis results obtained from time-lapse images of the sample 
area captured at 0, 15, 30, 45, and 60 min, we found that the growth rates of the cells at each 
time point were highly diverse and displayed broad distributions (Figure 4). To simplify the 






























analysis, we set integral bins for the growth rates and obtained cell count-based distributions 
shown in Figure 5. Assuming that the fraction of cells beyond the threshold of 2 were those 
had been replicated, obviously, such fractions treated with 2 and 4 µg/mL gentamicin 
increased over time, suggesting that a majority of cells were continuously growing. In the 
groups treated with 8 and 16 µg/mL gentamicin, even though the replication of most of cells 
were arrested, a tiny portion of cells still survived and completed one replication. By 
specifically examining the growth rates of these cells, we learned that all of them were in a 
trend to stop growing by 60 min. Regarding the effectiveness of eventually inhibiting cell 
growth, as depicted in Figure 6, MIC could be determined as 8 µg/mL, which agreed with 
the result from conventional broth dilution method (Figure 7).  
 




Figure 4. Normalized growth rate (Mean ± S.D.) versus incubation time.  
 
Figure 5. Number-based distribution of normalized single-cell growth rate for 
several thousand E. cloacae cells treated with 2, 4, 8, and 16 µg/mL of gentamicin. 

































Figure 6. MIC determination by reported AST approach. The curves were plotted 
by normalized fraction of replicated cells from each treated group versus time.  
 
Figure 7. (A) Graphic description of MIC determination by broth dilution method. 
(B) OD600 obtained after the bacteria were incubated for 16 h. 




In practice, clinical bacteria isolates are complex because antibiotic resistant and 
susceptible bacteria coexist. Especially if the portion of the resistant phenotype is extremely 
small, accurately assessing the antibiotic susceptibility of such sample still remains 
challenging. Herein, our AST platform was further employed to analyze an artificial sample 
containing a mixture of kanamycin resistant E. coli and kanamycin susceptible E. cloacae, 
where the number of resistant cells was extremely low. Cells were treated with 50 µg/mL 
kanamycin, which was effective enough to selectively allow E. coli proliferate, while kill E. 
cloacae. Figure 8 and 9 show a representative field of view selected from an area of 7.46 
mm ´ 7.12 mm and the corresponding plot of normalized growth rate versus time. 
Apparently, only one out of five bacteria was actively growing. Depicted in Figure 10 are 
single-cell growth rate distributions for a total 2189 cells in the sample area at different time 
points. If a value of 2 is set as the threshold to separate replicated and non-replicated 
populations, as illustrated in Figure 11, the fractions of replicated cells at 15, 30, 45, and 60 
min are 0, 0.05%, 0.82%, and 1.15%, respectively. In contrast, the majority remained non-
replication and their size shrank over time, indicating that they were sensitive to kanamycin. 
Further examining each cell growth rate curve confirmed that 25 cells (1.15% of total count) 
continuously multiplied while the others did not. Therefore, our method was able to 
distinguish antibiotic resistant phenotype from susceptible phenotype within 1 h, especially 
the portion of resistant subpopulation was as small as only about 1%. For comparison, 
conventional broth dilution was performed with sample volume of tested sample. The liquid 
medium turned to turbid after 20 h incubation, suggesting that our approach was powerful 




Figure 8. Time-lapse images of one representative area, where kanamycin resistant 
E. coli and susceptible E. cloacae cells coexist in the presence of 50 µg/mL of 
kanamycin, and corresponding post-processing binary images. Scale bar, 10 µm. 
Actively growing cells are marked with purple arrows.  
 
Figure 9. Single-cell growth rate of bacterial cells shown in Figure 5.  



























Figure 10. Number-based distribution of normalized single-cell growth rate for 
several thousand mixed bacterial cells treated with 50 µg/mL of kanamycin.  
 
Figure 11. Normalized fraction of replicated cells versus time. 
Despite the great performance in accurately determining the antibiotic susceptibility 
profiles for complicated bacterial samples, as the acquisition of a wide-field image 
containing several thousand cells takes about 4 minutes, testing multiple antibiotic 
concentrations simultaneously is still challenging. However, recently emerged ultrafast 
high-resolution WSI techniques [113, 114, 140]would raise the promise in solving this issue 
by completing the acquisitions of multiple wide-field images in one minute.  





























3.3 Materials and Methods  
3.3.1 Materials and instruments 
Mueller-Hinton (MH) broth, Luria-Bertani (LB) broth, ampicillin sodium salt, and 
gentamicin sulfate were purchased from Sigma-Aldrich (St. Louis, MO, USA). Agarose was 
obtained from Promega (Madison, WI, USA). Silicon wafer was purchased from University 
Wafer (Boston, MA, USA). Kanamycin sulfate, polystyrene petri dishes (diameter 100 mm), 
and glass microscope slides were purchased from Thermo Fisher Scientific (Waltham, MA, 
USA). Enterobacter cloacae (E. cloacae) (ATCC 13047) was purchased from the American 
Type Culture Collection (Manassas, VA, USA). A genetically engineered kanamycin 
resistant Escherichia coli (E. coli) strain was used as a model bacterium. Image acquisition 
was conducted using BZ-X800 All-in-One fluorescence microscope (Keyence Corporation, 
Japan). 
3.3.2 Bacterial cell culture 
As the bacteria used in this study are resistant to certain antibiotics, corresponding 
antibiotics were added into the culture medium for the selection purpose. E. cloacae and 
kanamycin resistant E. coli were cultured in LB medium supplemented with 50 µg/mL 
ampicillin and 50 µg/mL kanamycin, respectively. All the antibiotics solutions were 
sterilized by being filtered through 0.2 µm PVDF membrane (EMD Millipore, Burlington, 
MA, USA) prior to the addition to LB medium. After the stocked bacteria were inoculated 
in LB medium and pre-enriched in a 37 °C shaker for 3 hours, the cells were diluted with 
phosphate buffered saline (PBS) to desired concentrations for the testing.   
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3.3. Sample preparation 
First, two parallel microscope glass slides with two pieces of spacers (0.38 mm-thick 
silicon wafer) in between were placed in a petri dish. Next, MH medium with 0.6% (w/v) 
agarose suspended in it was sterilized by autoclaving at 121 °C for 15 min. After the media 
cooled down below 50 °C, antibiotic was added, and this molten medium was subsequently 
poured into a petri dish and filled the empty chamber between the glass slides. This petri 
dish was placed on a horizontal benchtop at room temperature. After the medium was 
sufficiently solidified, the cover glass slide was gently removed to present a thin gel pad 
with flat surface. Then, 2.5 µL bacterial suspension was carefully loaded onto the gel pad 
without disrupting the surface. After the drop completely evaporated, the glass slide and the 
thin gel pad together was taken out by cutting off the surrounding bulk gel and mounted the 
side of gel pad with bacteria on another glass slide for WSI.  
3.3.4 Whole slide imaging 
The aforementioned sandwiched glass slides were placed on the imaging stage of 
microscopy cell incubator, wherein the bacteria side of the gel was in contact with the 
supporting glass slide. After the horizontal plane of bacterial cells was focused by the 
objective lens, the boundary of sample area was determined by the auto-searching function 
of the Keyence microscope. Next, cells in 10 different FOVs throughout the sample area 
were focused one by one to ensure the autofocusing during the scanning. Subsequently, tiles 
of phase contrast images were continuously captured as the sample holder stage moved along 
a sequential path programmed by the imager software until the entire sample area was 
scanned. Herein, tiles (0.362 mm × 0.272 mm for each tile) were acquired by a 40× objective 
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lens (NA=0.60, S Plan Fluor ELWD Ph2, Nikon). Then, the BZ-X800 analyzer software 
automatically created a composite image by seamlessly stitching all the tiles together. After 
the first scanning, the temperature of the incubator was set to 37 °C. The scanning was 
repeated at 15, 30, 45, and 60 min after the temperature reached 37 °C.  
3.3.5 Image processing and data analysis 
The images obtained from WSI were processed by ImageJ software version 1.52i (NIH, 
Bethesda, MD, USA). First, the threshold was adjusted to enhance the contrast of the 
bacterial cells and render cells as black and background as white. Next, the area of each cell 
or microcolony developed from it was measured in pixels. Those below 15 pixels were 
filtered as they were considered as noise from the background. Then, these values of area 
were grouped according to the x-y coordinates on the image to deliver the change in size as 
each single cell grew over time. Finally, the normalized single-cell growth rate was 
calculated from the normalized change in size.  
3.3.6 WSI-based AST 
To evaluate the accuracy of our WSI-based AST method in the determination of MIC, 
E. cloacae and gentamicin were used as model bacterium and antibiotic, respectively. E. 
cloacae were treated with a series of concentrations (2, 4, 8, and 16 µg/mL) of gentamicin 
generated in the gel pad of bacterial culturing slides. The testing for each concentration was 
performed once using the aforementioned time-lapse WSI-based method to monitor the 
growth of each individual bacterial cell. 
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In addition, to assess the ability of our method in testing a polymicrobial and 
phenotypically heterogenous bacterial sample, we mixed kanamycin-sensitive E. cloacae 
and kanamycin-resistant E. coli together to stimulate the expected sample. Next, a WSI-
based test was performed by treating the cells from this sample with 50 µg/mL kanamycin.  
3.3.7 AST using broth dilution method 
For comparison, AST was also performed by the gold standard broth dilution method 
[39]. In this work, antibiotic was added to MH medium and serially diluted to desired 
concentrations. Subsequently, same number of bacteria used for WSI-based test were 
inoculated into test tubes containing 5 mL MH medium with antibiotics and one tube of 
antibiotic-free medium as a control. After incubation at 37 °C for 16-24 h, the MIC was 
determined as the lowest concentration at which no visible bacterial growth was observed. 
Here, bacterial growth was quantified by measurement of OD600 using UV-Vis 
spectrophotometer (Nanodrop 1000, Thermo Fisher Scientific). This test was conducted in 
triplicate.  
3.4 Conclusions 
In this study, we demonstrated a novel rapid and accurate AST method established on 
WSI, which enabled high-throughput analysis of single-cell growth rates regardless of the 
variations in bacteria size and shape. As a demonstration of employing this new method to 
perform AST, the MIC of E. cloacae against gentamicin was determined within the 
theoretically shortest time that ensures the growth of each individual bacterium is inhibited. 
Notably, our technique was able to rapidly identify antibiotic resistant cells from a large 
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population of antibiotic susceptible cells, in which the portion of resistant subpopulation was 
about 1%. In addition, microscopy imaging shows no limitation in analyzing cells in diverse 
size or shape, suggesting that this method can be generalized to most bacteria species. 
Therefore, our AST approach would show great potential in determining antibiotic 
susceptibility of complex clinical bacteria isolates. Moreover, owing to the feature of high-
throughput quantitative analysis, our approach can be applied to timely identifying the rising 
antibiotic resistance adapted to the treatment and guiding the adjustment of treatment 


















Whole Slide Imaging for High-throughput Monitoring 
Fungal Growth at Single-Cell Level and Its Application to 
Rapid Antifungal Susceptibility Testing 
4.1 Introduction 
Invasive fungal infections, especially those caused by Candida species, are associated 
with high morbidity and mortality to the immunocompromised population [141-144].  In the 
past a few decades, empirical use of antifungal agents has promoted the emergence and 
spread of drug resistance in fungi which are normally susceptible to the treatment [145, 146]. 
As recently reported, Candida auris have become multidrug resistant and thus life-
threatening [147-150]. Typically, healthcare providers employ antifungal susceptibility 
testing (AFST) to guide the prescription of antifungal drugs. The gold standard AFST 
methods, such as broth microdilution and disk diffusion, are based on the observation of 
visible fungal growth in the presence of antifungal drugs [151-153]. To facilitate 
standardized AFST, commercial automated instruments, such as Sensititre YeastOne 
(Thermo Fisher Scientific, MA, USA) and VITEK-2 (bioMérieux, France), have been 
developed [154]. However, the culture-based methods typically take up to several days 
[155], resulting in urgent need of rapid AFST to accelerate the initiation of appropriate 
antifungal treatment. Novel AFST approaches relying on the detection of specific genetic 
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mutations or changes of proteome corresponding to antifungal resistance by molecular 
techniques, such as DNA sequencing, real-time polymerase chain reaction (PCR), and 
matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF 
MS), could be promising alternatives [49, 156-163]. Although molecular methods are 
sensitive and fast, a full understanding of the mechanisms of antifungal resistance to certain 
drugs is essential for reliable results [156]. Thus, rapid AFST techniques without 
compromising accuracy are urgently needed. 
Herein, we report a novel AFST technique based on whole slide imaging (WSI) 
technique. As previously reported, we developed a WSI-based antibiotic susceptibility 
testing (AST) approach to determine the antibacterial susceptibility by high-throughput 
monitoring single-bacterium growth [164]. In this study, we used this approach for AFST. 
As a demonstration, we conducted time-lapse imaging of thousands of C. albicans cells and 
monitored single-cell growth. Antifungal susceptibility profiles of C. albicans against 
fluconazole was determined within 3 h, whereas the same results obtained from conventional 
broth dilution method took 72 h. 
4.2 Results and Discussion 
4.2.1. WSI-based monitoring fungal cell growth  
In this study, we adapted the same microbial culturing “sandwich slides” as depicted in 
Scheme 1 (Chapter 3) for WSI. C. albicans cells are immobilized on the interface between 
the gel and the supporting glass. Next, bright-field images of the entire sample area were 
acquired as the sample stage moves and seamlessly stitched together into one image. As a 
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demonstration, Figure 1 displays a composite image of a sample area (5.689 mm ´ 5.408 
mm). Zooming in the image enabled the visualization of individual cells, which were all in-
focus. Herein, using a 40´ objective lens, the imaging process took only 2 min. Considering 
that the doubling time of C. albicans is 1h in pure medium and it may be even longer during 
antifungal treatment, it was assumed that there was no observable cell growth during the 2 
min imaging time under microscope.  
To employ this system to monitor single-cell growth, the “sandwich” slides with C. 
albicans cell deposited in it were incubated at 37 °C and a humidity of 90%, under which 
condition the dimensions of the gel pad were not changed over the course of experiments. 
Subsequently, time-lapse imaging was conducted on the same sample area at 0.5, 1, 1.5, 2, 
2.5, and 3 h. After the time-lapse composite images were collected, the numbers of cells 
developed from the same cell at different time points were read from the images. Since each 
composite image was in gigabytes, we selected a small subarea containing 5 cells as a 
demonstration of monitoring cell growth (Figure 2). As a yeast, C. albicans proliferate 
through budding. That is, a small bud emerges on the mother cell and its size keeps growing 
until reaching a certain level. Then the budding recurred on the daughter cell. To address 
this special cell growth pattern, we used cell number to determine the cell growth rates, 
which was more accurate to indicate cell replication than using cell area change. For each 
individual cell, the normalized growth rate at time t was calculated using equation (1), where 
Nt and N0 are the numbers of cells with same location in the images captured at time t and 
time 0, respectively. Depicted in Figure 3 are the growth rate curves of 5 cells. Apparently, 
 
 75 
at each time point, the growth rates varied, emphasizing the necessities of analyzing a large 








Figure 1. A representative composite image captured by the reported platform. 







Figure 2. Time-lapse images of one representative area selected from the 










Figure 3. A representative single-cell growth rate of bacterial cells presented in 
Figure 2.  
4.2.2. Determination of minimal inhibitory concentration (MIC) by WSI-based AFST 
To investigate the ability of our method to determine antibiotic susceptibility, we 
performed tests through tracking cell growth of C. albicans in response to fluconazole 
treatments. Herein, the tested concentrations of fluconazole in gel pad were 0, 4, 8, 16, 32, 
64, and 128 µg/mL and the number of cells treated at each antibiotic concentration were 675, 
638, 644, 564, 644, 578, and 611, respectively. The populations were sufficiently large to 
show statistically significance in addressing the biological heterogeneity with respect to the 
growth rate. Based on the analysis results obtained from time-lapse images of the sample 
area captured at 0.5, 1, 1.5, 2, 2.5, and 3 h (Figure 4), we found that the growth rates of the 
cells at each time point were highly diverse and displayed broad distributions. To simplify 
the analysis, we set integral bins for the growth rates and obtained cell count-based 































distributions shown in Figure 5. Setting threshold of 2 to indicate those had been replicated, 
obviously, such fractions treated with 0, 4, 8, 16, and 32 µg/mL fluconazole increased over 
time, suggesting that a majority of cells were continuously growing. In the groups treated 
with 64 and 128 µg/mL fluconazole, the growth of every individual cell was inhibited. By 
plotting the fraction of replicated cells versus time, as depicted in Figure 6, MIC was 
determined as 64 µg/mL, which agreed with the result from conventional broth dilution 
method (Figure 7).  
 
Figure 4. Normalized growth rate (Mean ± S.D.) versus incubation time.  






































Figure 5. Number-based distribution of normalized single-cell growth rate for 
several thousand C. albicans cells treated with 0, 4, 8, 16, 32, 64, and 128 µg/mL 
fluconazole. In each histogram diagram, x-axis indicates normalized growth rates 
and y-axis indicates number-based fraction of cells.  











Figure 6. MIC determination by reported AFST approach. The curves were plotted 
by fraction of replicated cells from each treated group versus time.  
































Figure 7. (A) Graphic description of MIC determination by broth dilution method. 
(B) OD600 obtained experimentally after the bacteria were incubated for 72 h. 
4.3 Materials and Methods  
4.3.1 Materials and instruments 
As the composition of Sabouraud dextrose broth (SDB), dextrose and peptone were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Agarose was obtained from Promega 
(Madison, WI, USA). Silicon wafer was purchased from University Wafer (Boston, MA, 
USA). Chloramphenicol, fluconazole, polystyrene petri dishes (diameter 100 mm), and glass 
0 4 8 16
0 h
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microscope slides were purchased from Thermo Fisher Scientific (Waltham, MA, USA). 
Candida albicans (C. albicans) (strain SC5314) was received as a gift from Professor Anna 
Dongari-Bagtzoglou. Image acquisition was conducted using BZ-X800 All-in-One 
fluorescence microscope (Keyence Corporation, Japan). 
4.3.2 Fungal cell culture 
As the culture medium for C. albicans, SDB medium was prepared with 40 g/L dextrose, 
10 g/L peptone, and 0.05 g/L chloramphenicol. The pH of medium was adjusted to 5.6 and 
filtration sterilized through 0.2 µm PVDF membrane (EMD Millipore, Burlington, MA, 
USA). After overnight culturing of stocked C. albicans in a 37 °C shaker, the cells were 
diluted with phosphate buffered saline (PBS) to desired concentrations for the testing.   
4.3.3 Sample preparation 
First, two parallel microscope glass slides with two pieces of spacers (0.38 mm-thick 
silicon wafer) in between were placed in a petri dish. Next, SDB medium with 0.6% (w/v) 
agarose suspended in it was sterilized by autoclaving at 121 °C for 15 min. After the media 
cooled down below 50 °C, antibiotic was added, and this molten medium was subsequently 
poured into a petri dish and filled the empty chamber between the glass slides. This petri 
dish was placed on a horizontal benchtop at room temperature. After the medium was 
sufficiently solidified, the cover glass slide was gently removed to present a thin gel pad 
with flat surface. Then, 2.5 µL bacterial suspension was carefully loaded onto the gel pad 
without disrupting the surface. After the drop completely evaporated, the glass slide and the 
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thin gel pad together was taken out by cutting off the surrounding bulk gel and mounted the 
side of gel pad with bacteria on another glass slide for WSI.  
4.3.4 Whole slide imaging 
The aforementioned sandwiched glass slides were placed on the imaging stage of 
microscopy cell incubator, wherein the bacteria side of the gel was in contact with the 
supporting glass slide. After the horizontal plane of bacterial cells was focused by the 
objective lens, the boundary of sample area was determined by the auto-searching function 
of the Keyence microscope. Next, cells in 10 different FOVs throughout the sample area 
were focused one by one to ensure the autofocusing during the scanning. Subsequently, tiles 
of bright-field images were continuously captured as the sample holder stage moved along 
a sequential path programmed by the imager software until the entire sample area was 
scanned. Herein, tiles (0.362 mm × 0.272 mm for each tile) were acquired by a 40× objective 
lens (NA=0.60, S Plan Fluor ELWD Ph2, Nikon). Then, the BZ-X800 analyzer software 
automatically created a composite image by seamlessly stitching all the tiles together. After 
the first scanning, the temperature of the incubator was set to 37 °C. The scanning was 
repeated at 0.5, 1, 1.5, 2, 2.5, and 3 h after the temperature reached 37 °C.  
4.3.5 Image analysis 
The number of cells was read from the image. The group of numbers originated from 
the same cell were plotted over time to quantify the cell growth rate.  
4.3.6 WSI-based AFST 
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To evaluate the accuracy of our WSI-based AFST method in the determination of MIC, 
C. albicans and fluconazole were used as model fungus and antifungal agent, respectively. 
C. albican was treated with a series of concentrations (0, 4, 8, 16, 32, 64 and 128 µg/mL) of 
fluconazole generated in the gel pad of bacterial culturing slides. The testing for each 
concentration was performed once using the aforementioned time-lapse WSI-based method 
to monitor the growth of each individual fungal cell. 
4.3.7 AFST using broth dilution method 
For comparison, AFST was also performed by the gold standard broth dilution method 
[39]. In this work, fluconazole was added to SDB medium and diluted to a series of 
concentrations (0, 4, 8, 16, 32, 64 and 128 µg/mL). Subsequently, similar number of C. 
albicans cells used for WSI-based test were inoculated into test tubes containing 5 mL SDB 
medium with fluconazole and one tube of pure medium as a control. After incubation at 37 
°C for 72 h, the MIC was determined as the lowest concentration at which no visible cell 
growth was observed. Fungal cell growth was quantified by measurement of OD600 using 
UV-Vis spectrophotometer (Nanodrop 1000, Thermo Fisher Scientific). This test was 
conducted in triplicate.  
4.4 Conclusions 
In this study, we demonstrated a novel rapid and accurate AFST method based on WSI, 
which enabled high-throughput analysis of fungal growth rates. For the first time, the cell 
growth rate was calculated directly from the change in cell number, significantly improving 
the accuracy. As a demonstration of employing this new method for rapid AFST, the MIC 
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of C. albicans against fluconazole was determined within 3 h, whereas the conventional 
broth dilution method took 72 h. The developed AFST method shows significant 
improvement in term of rapidness compared to conventional method, which could play a 



















Summary and Outlook 
5.1 Summary  
Accurately measuring the number of viable microorganisms plays an essential role in 
microbiological studies. Since the conventional agar method of enumerating visible colonies 
is time-consuming and not accurate, efforts have been made towards overcoming these 
limitations by counting the invisible micro-colonies. However, none of studies on micro-
colony counting was able to save significant time or provide accurate results. Herein, we 
developed an on-glass-slide cell culture device that enables rapid formation of micro-
colonies on a 0.38 mm-thick gel film without suffering from nutrient and oxygen deprivation 
during bacteria culturing. Employing a phase contrast imaging setup, we achieved rapid 
microscopic scanning of micro-colonies within a large sample area on the thin film without 
the need of fluorescent staining. Using Escherichia coli (E. coli) as a demonstration, our 
technique was able to shorten the culturing time to within 5 h and automatically enumerate 
the micro-colonies from the phase contrast images. Moreover, this method delivered more 
accurate counts than the conventional visible colony counting methods. Due to these 
advantages, this imaging-based micro-colony enumeration technique provides a new 
platform for the quantification of viable microorganisms. 
Since conventional culture-based antibiotic susceptibility testing (AST) methods are too 
time-consuming (typically 24–72 h), rapid AST is urgently needed for preventing the 
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increasing emergence and spread of antibiotic resistant infections. Although several 
phenotypic antibiotic resistance sensing modalities are able to reduce the AST time to a few 
hours or less, concerning the biological heterogeneity, their accuracy or limit of detection 
are limited by low throughput. Here, we present a rapid AST method based on whole slide 
imaging (WSI)-enabled high-throughput sensing antibiotic resistance at single-bacterium 
level. The time for determining the minimum inhibitory concentration (MIC) was 
theoretically shortest, which ensures that the growth of each individual cell present in a large 
population is inhibited. As a demonstration, our technique was able to sense the growth of 
at least several thousand bacteria at single-cell level. Reliable MIC of Enterobacter cloacae 
against gentamicin was obtained within 1 h, while the gold standard broth dilution method 
required at least 16 h for the same result. In addition, the application of our method prevails 
over other imaging-based AST approaches in allowing rapid and accurate determination of 
antibiotic susceptibility for phenotypically heterogeneous samples, in which the number of 
antibiotic resistant cells was negligible compared to that of the susceptible cells. Hence, our 
method shows great promise for both rapid AST determination and point-of-care testing of 
complex clinical bacteria isolates. 
Since fungi have become multi-drug resistant and lethal, we utilized the WSI-based AST 
methods for rapidly and accurately determining antifungal susceptibility. For the first time, 
the cell growth rate was calculated directly from the change in cell number, rendering precise 
high-throughput analysis of fungal growth rates. As a demonstration of employing this new 
method for rapid antifungal susceptibility testing (AFST), the MIC of C. albicans against 
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fluconazole was shortened to within 3 h, whereas the conventional broth dilution method 
took 72 h. 
5.2 Outlook 
Although our WSI-based AST technique enables rapid and accurate testing for bacteria, 
fungi, and phenotypically heterogeneous samples, the single concentration of antimicrobial 
agent presents in one microscopy “sandwich” slides, which restrains this technique from 
being used for testing multiple concentrations simultaneously. Furthermore, the “sandwich” 
microbial culture slides developed in our laboratory is very cost-effective, especially 
compared to those sophisticated microfluidic devices. Although conventional optical 
microscopes are commonly equipped in every clinical or biomedical laboratory, 
microscopes with autofocus function are expensive and only available for specific purposes, 
such as digital pathology. Hence, our AST technique still has not met the needs for point-of-
care diagnosis.  
To eventually apply our WSI-based AST techniques to point-of-care diagnosis, there 
are a few ways to improve the performance of this technique, in the meanwhile decrease its 
cost. 
First, the microscopy scanning speed can be significantly increased to enable testing 
multiple concentrations of antimicrobial agent simultaneously for the same microbial sample. 
As the general principle of whole slide imaging employed in our work, a large composite 
image was generated by stitching numerous images of single FOV together. Thus, the 
exposure time for each capture of single FOV determines the total time for the microscopy 
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scanning. Besides, employing larger magnification of objective lens results in higher 
resolution, but it takes longer time for microscopy scanning. Since it is feasible to engineer 
“sandwich” slides, in which the gel pad is split into multiple pieces containing various 
concentrations, the only technical barrier is the lacking of advanced optical sensors to 
capture images of microorganisms immobilized in the multiple pieces of gel pad 
simultaneously. As a recently emerged imaging technology, wide-field lens-free on-chip 
imaging seems to be a promising modality to overcome the technical barrier [165]. The 
imaging FOV can reach up to 18.15 cm2 and the image acquisition time is less than 1 s, 
which would be sufficient for the purpose of rapid multiple testing.  
Second, conventional optical microscopy-based diagnosis requires well-trained 
technician and eligible laboratory infrastructure, which are limited in developing countries, 
especially in infection-endemic regions. Thus, it is essential to further reduce the cost and 
improve the portability of the reported AST setup. As a future direction, smartphone camera 
can be used to replace the lens of conventional optical microscope. In a recent study, a 
smartphone-based microscope was designed for wide-field imaging parasite eggs and 
diagnosis of schistosomiasis [166]. By incorporating a battery-powered X-Y stage, this 
handheld smartphone-based microscope is able to produce high-resolution images of about 
1 cm2 FOV, which shows great promise in being used for high-throughput AST. Furthermore, 
as a significant improvement, although the smartphone camera is generally equipped with 
low numerical aperture, the application of advanced deep learning algorithms can render 
high-resolution images, matching the performance of conventional optical microscope with 
high-end objective lens [167, 168].  
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Third, since microorganism samples are typically from blood, urine, or stool, and 
isolating the microorganisms is time-consuming, it is critical to develop novel AST methods 
to directly test original clinical samples. As machine learning or deep learning has been 
applied to the differentiation of different microbial species [169, 170], it is believed that 
advanced algorithms can be developed for the differentiation of microorganisms from non-
microbial substance in the future. Therefore, the total time for AST would be significantly 
shortened.  
Fourth, although 2-fold dilution is generally accepted for AST, accurately identification 
of real MIC is essential. To test numerous concentrations of antimicrobial agent in one test, 
it would be great to limit the size of each gel pad to as small as possible. Therefore, as the 
future work, the minimum number of microorganisms for providing results as accurate as 
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